Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin vs Clopidogrel for Uterine Perfusion in RPL
NCT01635426Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Mar 2012
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of clopidogrel in recurrent pregnancy loss (RPL), sponsored by Ain Shams University. Primary endpoint: Uterine artery pulsatility index at 2 months. Status: unknown.
02
Drugs
clopidogrel
03
Conditions
recurrent pregnancy loss (RPL)
Beyond the preview
Go deeper on NCT01635426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01635426.